Bisphosphonate use for osteoporosis in postmenopausal women may inhibit occurrence of malignant microcalcification in breast tissue

Med Hypotheses. 2006;67(1):202-3. doi: 10.1016/j.mehy.2005.07.024. Epub 2005 Sep 13.
No abstract available

Publication types

  • Letter

MeSH terms

  • Bone Density Conservation Agents / pharmacology
  • Breast / metabolism
  • Breast / pathology*
  • Breast Diseases / etiology*
  • Calcinosis / etiology*
  • Calcium / metabolism
  • Calcium Metabolism Disorders
  • Diphosphonates / therapeutic use*
  • Female
  • Humans
  • Osteoporosis, Postmenopausal / drug therapy*
  • Postmenopause

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Calcium